Concepedia

Antimicrobial Approval Processes

Antimicrobial Approval Processes is a formal institutional framework that governs the systematic evaluation, authorization, and oversight of antimicrobial agents for clinical use, distinguishing it from general medication management through its focus on optimizing antimicrobial selection, minimizing resistance development, and ensuring evidence-based prescribing within healthcare settings.

50

Publications

3.2K

Citations

229

Authors

128

Institutions

Publications per year

2017–2026

12

Parents

Publications

50

Effects of Requiring prior Authorization for Selected Antimicrobials: Expenditures, Susceptibilities, and Clinical Outcomes

A. Clinton White, Robert L. Atmar, Joan Wilson et al. · Clinical Infectious Diseases · 1997 · 369 citations · Full text

, , +14

Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications

Katherine H. Luepke, Katie J. Suda, Helen W. Boucher et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2016 · 348 citations · Full text

, , +17

Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures

Charlotte Brives, Jessica Pourraz · Palgrave Communications · 2020 · 319 citations · Full text

, , +16

Antibiotic and Chemotherapy

Postgraduate Medical Journal · 1974 · 158 citations

, , +13

APPROVED: New Antimicrobial Stewardship Standard.

PubMed · 2016 · 157 citations

, , +11

1–5 of 50

Authors

229

  1. JH
    John H. Powers

    National Institute of Allergy and Infectious Diseases, United States

    3 publications · 71 citations

    3

    h-index

  2. MG
    Mark Goldberger

    Center for Drug Evaluation and Research, United States

    2 publications · 146 citations

    2

    h-index

  3. CK
    Charles Knirsch

    Pfizer (United States), United States

    2 publications · 140 citations

    2

    h-index

  4. JR
    John Rex

    The University of Texas Health Science Center at Houston, United States

    2 publications · 186 citations

    2

    h-index

  5. NO
    Neil O. Fishman

    University of Pennsylvania, United States

    2 publications · 43 citations

    2

    h-index

1–5 of 229

Institutions

128

  1. Tufts University

    Medford, United States

    3 h-index

    3 publications

    510 citations

  2. The University of Texas Health Science Center at Houston

    Houston, United States

    3 h-index

    3 publications

    335 citations

  3. Norwegian Institute of Public Health

    Oslo, Norway

    2 h-index

    4 publications

    104 citations

  4. George Washington University

    Washington, United States

    2 h-index

    2 publications

    141 citations

  5. United States Food and Drug Administration

    Silver Spring, United States

    2 h-index

    6 publications

    181 citations

  6. The Royal Melbourne Hospital

    Melbourne, Australia

    2 h-index

    5 publications

    191 citations

  7. AstraZeneca (United States)

    Wilmington, United States

    2 h-index

    3 publications

    261 citations

  8. GlaxoSmithKline (United States)

    Philadelphia, United States

    2 h-index

    3 publications

    268 citations

1–8 of 128

Venues

  1. Clinical Infectious Diseases

    CID · 10 publications · 998 citations

    10

    h-index

  2. The Medical Journal of Australia

    MJA · 3 publications · 113 citations

    3

    h-index

  3. American Journal of Health-System Pharmacy

    AJHP · 2 publications · 46 citations

    2

    h-index

  4. PubMed

    Repository · 2 publications · 174 citations

    2

    h-index

  5. New England Journal of Medicine

    NEJM · 2 publications · 125 citations

    2

    h-index

1–5